Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
27. August 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 16714
Articles 1 - 20 / 334261
Financial toxicity among adult cancer survivors in Singapore: does it exist?
Singapore Med J
Ng WI, Yuen KH, Meng T, Tey CSJ, Soon YY, Ho CHF, Yoong SJ, Gibbons B, Vellayappan BA.
PMID: 42658157 [PubMed - indexed for MEDLINE]
Non-pharmacological interventions and quality of life in female survivors of hormone receptor-positive breast cancer receiving adjuvant endocrine therapy: A systematic review.
An Sist Sanit Navar
Arias-Martínez A, Escalada-Hernández P, Pimentel-Parra GA, García-Vivar C, Soto-Ruiz N.
PMID: 42657993 [PubMed - indexed for MEDLINE]
Efficacy and Safety of Viscum album L. in Patients With Triple-Negative Breast Cancer Receiving Immune Checkpoint Inhibitors: A Protocol for an Open-Label Randomized Clinical Trial.
Integr Cancer Ther
Lee JY, Ko EJ, Lee SH, Hong SE, Hyun MH.
PMID: 42657864 [PubMed - indexed for MEDLINE]
Perceived inequalities and cultural inclusivity in UK Breast Cancer Information and Care: a mixed method study.
JPRAS Open
Corriero AC, Fareed FFI, Rehman U, Tandanu E, Baczynska AJ, Antoniou P, Bakko F, Ezzat A, Filson S, Khatib M, Cavale N, United Kingdom Plastics Research Collaborative Collaborators.
PMID: 42657287 [PubMed]
Oral selective estrogen receptor degraders and biomarker-driven therapy in ER-positive breast cancer: mechanisms, clinical evidence, and future directions.
Front Oncol
Alasheev AY, Hamama R, Petersen EV, Maximov PY.
PMID: 42657161 [PubMed]
From static snapshots to longitudinal trajectories: artificial intelligence in women's reproductive and ovarian health.
Front Endocrinol (Lausanne)
Liu Y, Liu Y, Zhao Y, Luo Y, Hao X.
PMID: 42657071 [PubMed - indexed for MEDLINE]
Sarcopenia and inflammatory markers in early-stage breast cancer: a retrospective case-control study of NLR, MLR, RDW-CV, and HRR in middle-aged and elderly women.
Front Surg
Liu Y, Zhai X, Wang Z, Jia W.
PMID: 42656743 [PubMed]
Single cell mapping of B and T cell dynamics in breast cancer lymph node metastasis.
Front Bioinform
Khan S, Jamil S, Hamza M, Attique Z, Zhang S.
PMID: 42656703 [PubMed]
Efficacy, safety, and PD-L1-defined outcomes of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis.
Front Immunol
Ma C, Teoh HK, Qiu D, Zhang Y, Yang S, Zhao Y, Zhao C, Ong HT.
PMID: 42656671 [PubMed - indexed for MEDLINE]
A preliminary exploration of the mechanism of endometrial cancer development induced by intestinal flora diversity and its metabolites.
Front Cell Infect Microbiol
Sun Y, Li J, Chen J, Peng H, Shao Y, Wu Z.
PMID: 42656427 [PubMed - indexed for MEDLINE]
Selenium nanoparticles for breast cancer: mechanisms, delivery strategies, and translational challenges.
Front Oncol
Ni H, Fu X, Chen X, Zhao L.
PMID: 42656336 [PubMed]
Case Report: A diagnostic dilemma: metachronous pancreatic metastasis from high-grade serous ovarian carcinoma.
Front Oncol
Baraka B, Al-Ani M, Afife A, Soomro I, Madhusudan S.
PMID: 42656280 [PubMed]
Longitudinal evaluation of health-related quality of life in Chinese patients with early-stage HER2-positive breast cancer undergoing neratinib extended adjuvant therapy: a real-world prospective cohort study.
Front Oncol
Liang X, Guo Z, Wei J, Gui A, Jian M, Min J, Wang M, Ma S.
PMID: 42656231 [PubMed]
Human epidermal growth factor receptor 2-directed therapeutics and their role in changing the natural course of breast cancer.
Philos Trans R Soc Lond B Biol Sci
Sliwkowski M.
PMID: 42656142 [PubMed - indexed for MEDLINE]
Chlamydia trachomatis Infection as a Risk Factor for Ovarian Carcinoma.
Microorganisms
Puolakkainen M, Paavonen J, Brunham RC.
PMID: 42654983 [PubMed]
The Role of Adjuvant Nonavalent HPV Vaccination After LLETZ in Patients with Isolated CIN2: A Controlled Cohort Study.
Pathogens
Pinto V, Dellino M, Cerbone M, Di Naro E, Lepera A, Tafuri S, Cazzato G, Cicinelli E.
PMID: 42654751 [PubMed - indexed for MEDLINE]
Preoperative Inflammatory Markers as Predictors of Ovarian Tumor Malignancy: A Retrospective Diagnostic Study.
Medicina (Kaunas)
Gruber D, Bina AM, Abu-Awwad A, Tinei OV, Abu-Awwad SA, Citu C, Ratiu A, Huidu B, Costescu S, Popa ZL.
PMID: 42654510 [PubMed - indexed for MEDLINE]
Exploring the Possible Role of Endometriosis-Associated Dysbiosis in Endometrial Carcinogenesis.
Medicina (Kaunas)
Anastasiu CV, Dimienescu OG, Dinu, Moga MA, Grigorescu OD, Gugiu G, Bisoc A.
PMID: 42654474 [PubMed - indexed for MEDLINE]
Beyond Weight Loss: A Comprehensive Review of Integrated Pharmacotherapy and Metabolic Bariatric Surgery in Endometrial Cancer Care.
Medicina (Kaunas)
Innocenzi C, Goglia M, Reitano E, Pavone M, Fiorenza G, Orsi M, Querleu D, Giménez ME, Silecchia G, Bizzarri N, Fagotti A, Fanfani F, Marescaux J, Forgione A.
PMID: 42654468 [PubMed - indexed for MEDLINE]
Exploratory Analysis of Systemic Inflammatory Indices Across Locoregional Tumor Progression Parameters in Cervical Cancer: The CERTIFIKO Prospective Study.
Medicina (Kaunas)
Ronsini C, Di Nuzzo A, Solazzo MC, Scaffa C, Ascione C, Chiantera V.
PMID: 42654467 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 334261
Page 1 of 16714
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy